تقييم الحالة الصحية الفموية عند الأطفال المصابين بالربو والمعالجين بـدواء Budesonide الاستنشاقي
Abstract
الهدف من البحث : دراسة تأثير استخدام دواء ((Budesonide المضاد للربو على الصحة الفموية عند الأطفال المصابين بالربو خلال فترة متابعة لمدة سنة واحدة. المواد والطرائق : شملت العينة العشوائية 30 طفلاً مصاباً بالربو تراوحت أعمارهم بين (5- 10) سنوات بمتوسط عمري (7.42) من مراجعي قسم الأطفال في مشفى الأسد الجامعي- اللاذقية، بحيث كانت شدة الربو عندهم متوسطة مستمرة ، وبحاجة لاستخدام Budesonide"" الدواء الاستنشاقي المضاد للربو. تم تقييم النخر السني ، النزف اللثوي ، اللويحة السنية و pH اللعاب لكل طفل قبل إعطاء الدواء وبعده وذلك خلال فترة المتابعة (3 – 6 – 9- 12 ) شهراً. النتائج : أظهرت النتائج ارتفاعاً في مشعر DMFT، dmft، مشعر النزف اللثوي واللويحة السنية بعد المتابعة لمدة 12 شهر حيث (P<0.05) بينما لم يكن هناك أي فرق إحصائي هام في قيمة pH اللعاب . الاستنتاجات : إن استخدام الBudesonide الدواء الاستنشاقي المضاد للربو عند الأطفال يسبب زيادة في مشعر النخر السني وتراجعاً في الحالة الصحية اللثوية عند المعالجين به خلال فترة المتابعة. Aim of study:The purpose of this study is to evaluate the effect of antiasthma drug (Budesonide) on oral health of asthmatic children during one year of treatment. Materials and Methods: Thirty children with asthma aged (5-10) years were selected from the children who presented to children´s section at AL-Assad University Hospital in Lattakia with medium asthma severity and they needed to use antiasthma inhaled drug (Budesonide).This study have evaluated dental caries, gingival bleeding, dental plaque and saliva pH for each child before and after treatment with Budesonide in (3-6-9-12) months. Results: The results showed increasing in DMFT, dmft indices ,gingival bleeding index and dental plaque after follow- up for 12 months (P˂0.05), while there wasn̛ t any significant statistical difference in saliva pH value. Conclusions: The use of antiasthma inhaled drug (Budesonide) in asthma children caused increasing in dental caries index and reduction gingival status in patients who have been treated with this drug.Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.